Cleared Traditional

K830869 - POLYCHACO INDIRECT IMMUNOFLUORESCENCE

K830869 is an FDA 510(k) clearance for POLYCHACO INDIRECT IMMUNOFLUORESCENCE, manufactured by Parasitic Disease Consultants. The device is a Class 2 Microbiology device with product code GLZ cleared through the Traditional 510(k) pathway after a 146-day FDA review.

K830869 · Parasitic Disease Consultants · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1983
Decision
146d
Days
Class 2
Risk

K830869 is an FDA 510(k) clearance for the POLYCHACO INDIRECT IMMUNOFLUORESCENCE. Classified as Antigens, If, Toxoplasma Gondii (product code GLZ), Class II - Special Controls.

Submitted by Parasitic Disease Consultants (Mchenry, US). The FDA issued a Cleared decision on August 11, 1983 after a review of 146 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Parasitic Disease Consultants devices

FDA 510(k) Submission Details - K830869

510(k) Number K830869 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1983
Decision Date August 11, 1983
Days to Decision 146 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
44d slower than avg
Panel avg: 102d · This submission: 146d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GLZ Device Classification - Class 2, Special Controls

Product Code GLZ Antigens, If, Toxoplasma Gondii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GLZ Antigens, If, Toxoplasma Gondii

All 9
Devices cleared under the same product code (GLZ) and FDA review panel - the closest regulatory comparables to K830869.
TOXO IGM TEST
K880007 · Gull Laboratories, Inc. · Mar 1988
FIAX TOXO-M ANTIBODIES TEST KIT
K850591 · Intl. Diagnostic Technology · Apr 1985
ANTI-TOXOPLASMA GONDII KIT
K842664 · Amico Lab, Inc. · Aug 1984
TOXOPLASMA ANTIBODY TEST SYSTEM
K791571 · Zeus Scientific, Inc. · Sep 1979
FIAX TEST KIT FOR ANTI-TOXOPLASMA ANTIBO
K790464 · Intl. Diagnostic Technology · Jun 1979
QUANTAZYME TOXOPLASMA
K790360 · Bio-Rad · May 1979